1-7 of 7
Nishan Sengupta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improvement of Patient-Reported Outcomes Among Heavily Pretreated Patients with Lower-Risk Myelodysplastic Syndromes and High Transfusion Burden Treated with Imetelstat on the IMerge Phase 3 Trial

Mikkael A. Sekeres, Maria Diez-Campelo, Amer M. Zeidan, Uwe Platzbecker, Antoine Regnault, Kristin Creel, Nishan Sengupta, Ying Wan, Libo Sun, Qi Xia, Tymara Berry, Souria Dougherty, Sheetal Shah, Shyamala Navada, Valeria Santini, David Valcárcel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6479.
https://doi.org/10.1182/blood-2023-181103
Published: 2023
Journal Articles

Durable Transfusion Independence in Lower-Risk Myelodysplastic Syndrome (LR-MDS) Is Associated with Better Survival: A Population Level Analysis Based on a Large US Health Insurance Claims Database

Rami S. Komrokji, Nishan Sengupta, Dylan Supina, Shyamala Navada, Ravi Potluri, Rohit Tyagi, Tim Werwath, Zhuoer Xie, Eric Padron, David A Sallman
Journal: Blood
Blood (2023) 142 (Supplement 1): 2440.
https://doi.org/10.1182/blood-2023-180797
Published: 2023
Journal Articles

Comparative Evaluation of Ibrutinib in Treatment of Chronic Lymphocytic Leukemia Using Simulation Modeling

Siyang Peng, Feng Pan, Sonja Sorensen, Emily Dorman, Yingxin Xu, Rachel Sallum, Maren Gaudig, Nishan Sengupta, PhD, Mark Wildgust, Steve Sun
Journal: Blood
Blood (2014) 124 (21): 1299.
https://doi.org/10.1182/blood.V124.21.1299.1299
Published: 2014
Journal Articles

Evaluation of Ibrutinib in Treatment of Mantle Cell Lymphoma: A Treatment Comparison Using a Simulation Model

Siyang Peng, Feng Pan, Sonja Sorensen, Emily Dorman, Yingxin Xu, Rachel Sallum, Maren Gaudig, Nishan Sengupta, PhD, Mark Wildgust, Steve Sun
Journal: Blood
Blood (2014) 124 (21): 2596.
https://doi.org/10.1182/blood.V124.21.2596.2596
Published: 2014
Journal Articles

Rivaroxaban for Prevention of Venous Thromboembolism after Total Knee Replacement: Impact on Healthcare Costs Based on the RECORD4 Study.

Louis Kwong, Nishan Sengupta, Michael Lees
Journal: Blood
Blood (2008) 112 (11): 1289.
https://doi.org/10.1182/blood.V112.11.1289.1289
Published: 2008
Journal Articles

Will Rivaroxaban Be Cost-Effective for Prevention of Venous Thromboembolism after Total Hip Replacement in US Patients?

Louis Kwong, Alexander Diamantopoulos, Fiona Forster, Nishan Sengupta, Michael Lees
Journal: Blood
Blood (2008) 112 (11): 1290.
https://doi.org/10.1182/blood.V112.11.1290.1290
Published: 2008
Journal Articles

Rivaroxaban for Prevention of Venous Thromboembolism after Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study.

Louis Kwong, MD, Michael Lees, M.COM, Nishan Sengupta, PHD
Journal: Blood
Blood (2007) 110 (11): 1874.
https://doi.org/10.1182/blood.V110.11.1874.1874
Published: 2007